Skip to main content

Table 3 Student's T-test for the IHC reactive tumor cells versus their adjacent infiltrating lymphoid cell counterparts

From: Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors

  1. LM Leiomyoma, LMS Leiomyosarcoma, LMS—Rec Recurrent leiomyosarcoma, LMS—Met Metastatic leiomyosarcoma, EES Endometrial stromal sarcoma, STUMP Smooth muscle tumor of uncertain malignant potential, TC Tumor cell, LC Lymphoid cell, SRC Sarcoma, PD-L1 Programmed death-ligand 1, PD-1 Programmed cell death protein 1, CTLA-4 Cytotoxic T-lymphocyte-associated protein 4, IDO Indoleamine 2,3-dioxygenase, NS Total negative stain; Red, significant difference (P-values ≤ 0.05); Blue, borderline significant difference (0.05 p-value < 0.1).